BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹100 Cr | ₹86 Cr | ₹83 Cr | ₹76 Cr | ₹76 Cr |
What is the latest Total Non-Current Assets ratio of BAL PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹86 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹76 Cr |
How is Total Non-Current Assets of BAL PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 17.19 | |
| Mar2024 | ₹86 Cr | 3.41 | |
| Mar2023 | ₹83 Cr | 9.07 | |
| Mar2022 | ₹76 Cr | 0.04 | |
| Mar2021 | ₹76 Cr | - | |
Compare Total Non-Current Assets of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹117.7 Cr | 1.8% | -1.3% | -38.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 1.8% |
-1.3% |
-38.6% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses